Evidence map›Paper›PMID 40300589›Full record

SynthesisNeuroendocrinology2025

Impact of Sex and Deprivation on Neuroendocrine Tumour Survival: Challenges of Heterogeneous Data.

Ailbhe Lawlor, Harriet Wylde, Marie Line El Asmar, Benjamin Easton White, John Ramage, Mieke Van Hemelrijck, Beth Russell

Abstract readSystematic Review
In one paragraph

Synthesis in Neuroendocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ailbhe LawlorTranslational Oncology and Urology Research, King's College London, London, UK, ailbhe.lawlor@kcl.ac.uk.
Harriet WyldeTranslational Oncology and Urology Research, King's College London, London, UK.
Marie Line El AsmarHampshire Hospitals NHS trust, Basingstoke Hants, Basingstoke, UK.
Benjamin Easton WhiteHampshire Hospitals NHS trust, Basingstoke Hants, Basingstoke, UK.
John RamageHampshire Hospitals NHS trust, Basingstoke Hants, Basingstoke, UK.
Mieke Van HemelrijckTranslational Oncology and Urology Research, King's College London, London, UK.
Beth RussellTranslational Oncology and Urology Research, King's College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

<p>Background: For decades, the incidence of neuroendocrine tumours (NETs) has been steadily increasing. Existing research suggests that patient sociodemographic characteristics, such as sex and deprivation, may play a role in who survives a NET diagnosis. This systematic review identifies the available evidence assessing the impact of sex and deprivation on the prognosis of patients diagnosed with NETs. Summary: Using protocol-driven search terms, Embase and Ovid were searched in July 2024. The search identified 2,041 unique citations, of which 66 articles were subsequently included. Findings were reported by geographical location. Included studies indicate a female survival advantage in North America and England, but the impact of sex on NET prognosis in wider European and Asian countries is less clear. The impact of deprivation on NET prognosis was assessed in North America, with one study conducted in Europe. Key Messages: Significant data heterogeneity across studies poses challenges to comparability between studies and hinders statistical analyses of these data. In North America and England, females diagnosed with NETs tend to survive longer than males. Existing single-centre studies do not provide conclusive evidence on the impact of sex on NET survival in Asian countries, and a greater number of population-based studies are needed. Future research should also focus on addressing heterogeneity across NET research to allow for more robust evidence synthesis, providing increased accuracy and generalisability of study results. </p>.

Indexed as

Neuroendocrine TumorsFemaleHumansMaleNorth AmericaPrognosisSex FactorsDeprivationNeuroendocrine tumoursPrognosisSexSocioeconomic statusSurvival

Identifiers

PMID40300589
PMCPMC12176355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.